Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital ...
Intel Capital is set to spin out from its parent company later this year after serving as Intel's venture investing arm since 1991.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback